Search for content, post, videos

Novo Nordisk to lower U.S. prices of several pre-filled insulin pens and vials

Novo Nordisk has announced it is lowering the US list prices of several insulin products by up to 75% for people living with type 1 and type 2 diabetes. Products include both pre-filled pens and vials of basal (long-acting), bolus (short-acting) and pre-mix insulins, specifically Levemir, Novolin
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.